Search research articles
Contact Us
Filters
Showing results (51-60 of 108) with videos related to
Page
of 11
Sort By:
Annals of Palliative Medicine
|
July 9, 2021
Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong Kong
Kwok Ying Chan, Harinder Gill, Thomas Sau Yan Chan, et al.
Blood
|
March 11, 2014
A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML
Cheuk Him Man, Stephen S Y Lam, Murphy K H Sun, et al.
Haematologica
|
March 31, 2015
Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
Harinder Gill, Cheuk-Him Man, Alvin H W Ip, et al.
Chinese Medical Journal
|
August 31, 2012
Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady
Yat-Fung Shea, Chi-Ho Lee, Harinder Gill, et al.
American Journal of Hematology
|
March 21, 2013
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor
Anskar Y H Leung, Eric Tse, Yu-Yan Hwang, et al.
Annals of Hematology
|
November 12, 2024
Mixed-phenotype leukemia with TCF3::ZNF384 fusion presenting as an isolated mediastinal mass
Wing-Yan Au, Chit Chow, Ka-Fai To, et al.
Annals of Hematology
|
August 15, 2024
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, et al.
Clinical Transplantation
|
February 14, 2012
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment
Thomas S Y Chan, Yu-Yan Hwang, Harinder Gill, et al.
Annals of Hematology
|
January 13, 2025
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, et al.
Annals of Hematology
|
February 4, 2026
Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice
Garret M K Leung, Joycelyn P Y Sim, Thomas S Y Chan, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 108) with videos related to
Sort By:
Page
of 11
Annals of Palliative Medicine
|
July 9, 2021
Early integrated palliative care for haematology cancer patients-the impact on symptom burden in Hong Kong
Kwok Ying Chan, Harinder Gill, Thomas Sau Yan Chan, et al.
Blood
|
March 11, 2014
A novel tescalcin-sodium/hydrogen exchange axis underlying sorafenib resistance in FLT3-ITD+ AML
Cheuk Him Man, Stephen S Y Lam, Murphy K H Sun, et al.
Haematologica
|
March 31, 2015
Azacitidine as post-remission consolidation for sorafenib-induced remission of Fms-like tyrosine kinase-3 internal tandem duplication positive acute myeloid leukemia
Harinder Gill, Cheuk-Him Man, Alvin H W Ip, et al.
Chinese Medical Journal
|
August 31, 2012
Delayed diagnosis of 22q11.2 deletion syndrome in an adult Chinese lady
Yat-Fung Shea, Chi-Ho Lee, Harinder Gill, et al.
American Journal of Hematology
|
March 21, 2013
Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor
Anskar Y H Leung, Eric Tse, Yu-Yan Hwang, et al.
Annals of Hematology
|
November 12, 2024
Mixed-phenotype leukemia with TCF3::ZNF384 fusion presenting as an isolated mediastinal mass
Wing-Yan Au, Chit Chow, Ka-Fai To, et al.
Annals of Hematology
|
August 15, 2024
A randomized, double-blind, placebo-controlled phase 3 study to assess efficacy and safety of ropeginterferon alfa-2b in patients with early/lower-risk primary myelofibrosis
Ghaith Abu-Zeinah, Albert Qin, Harinder Gill, et al.
Clinical Transplantation
|
February 14, 2012
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment
Thomas S Y Chan, Yu-Yan Hwang, Harinder Gill, et al.
Annals of Hematology
|
January 13, 2025
PARADIGM-PV: a randomized, multicenter phase 4 study to assess the efficacy and safety of ropeginterferon alfa-2b in patients with low- or high-risk polycythemia vera
Abdulraheem Yacoub, Ghaith Abu-Zeinah, Albert Qin, et al.
Annals of Hematology
|
February 4, 2026
Efficacy and safety of belumosudil for refractory chronic graft-versus-host disease in routine practice
Garret M K Leung, Joycelyn P Y Sim, Thomas S Y Chan, et al.
Page
of 11